Top news of the week: 12.01.2022.
Startups
WuXi Global Forum 2022 - Advancing Breakthroughs for Patients
WuXi Global Forum 2022 - Advancing Breakthroughs for Patients
Preparing for the Next Plague
SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges
The Renaissance Man of Venture Capital
Lux Capital’s Josh Wolfe is channeling sci-fi to bank on “the inevitable arrow of progress.”
From Beacon Hill to Biotech
Growing up, I was raised on the understanding that civic engagement is a responsibility and that the right to vote is sacred. They afford us the opportunities to make our communities, our ...
Biotech is set for a geopolitical stress test
Diseases have no borders, but biotechnology companies do. The sector has been immune to U.S.-China tensions so far, but political risks are building.
With Alnylam in rear view, Maraganore wants to be a biotech multiplier, matchmaker and mentor
After 19 years at the helm of Alnylam, John Maraganore, Ph.D., is not wasting any time getting started on the next phase of his career.
US VC firms raise nearly $13B in the first week of 2022
The new year is barely a week old and US venture capital firms have already raised about $12.8 billion across 15 funds, according to PitchBook data.
As three biotechs head to Wall Street, a battered sector braces for a pullback
Amylyx, CinCor and Vigil raised about $480 million combined, a sign of continued investor interest in biotech IPOs. But industry analysts expect fewer and smaller offerings in 2022 due to ...